Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 7102514, 9 pages
https://doi.org/10.1155/2017/7102514
Review Article

Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta-Analysis of Randomized Controlled Trials

1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
3School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Correspondence should be addressed to Lixiu Yu; moc.361@515021xly

Received 4 February 2017; Accepted 10 October 2017; Published 12 November 2017

Academic Editor: Ghee T. Tan

Copyright © 2017 Lixiu Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Favoriti, G. Carbone, M. Greco, F. Pirozzi, R. E. M. Pirozzi, and F. Corcione, “Worldwide burden of colorectal cancer: a review,” Updates in Surgery, vol. 68, no. 1, pp. 7–11, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Boyle and J. S. Langman, “ABC of colorectal cancer: Epidemiology,” British Medical Joural, vol. 321, no. 7269, pp. 805–808, 2000. View at Google Scholar
  3. M. L. McCullough, A. S. Robertson, A. Chao et al., “A prospective study of whole grains, fruits, vegetables and colon cancer risk,” Cancer Causes & Control, vol. 14, no. 10, pp. 959–970, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. P. A. Kurup, N. Jayakumari, M. Indira et al., “Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer. Composition, intake, and excretion of fiber constituents,” American Journal of Clinical Nutrition, vol. 40, no. 4, pp. 942–946, 1984. View at Google Scholar · View at Scopus
  5. P. Siler, S. D'Ugo, D. Benavoli et al., “Metachronous splenic metastasis from colonic carcinoma five years after surgery: A case report and literature review,” Southern Medical Journal, vol. 102, no. 7, pp. 733–735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. X. L. Fang, “Study the curative effect of advanced stage colon carcinoma treated by LOHP combined with 5-FU/CF,” Chinese Journal of Clinical Rational Drug Use, vol. 2, no. 8, 2009. View at Google Scholar
  7. C.-S. Lu, P.-Y. Chang, Y.-G. Chen, J.-H. Chen, Y.-Y. Wu, and C.-L. Ho, “Stage III colon cancer: The individualized strategy of adjuvant chemotherapy for aged under and over 70,” PLoS ONE, vol. 10, no. 9, Article ID e0138632, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. F. A. Sinicrope, M. R. Mahoney, T. C. Smyrk et al., “Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.,” Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, no. 29, pp. 3664–3672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Masuda, K. Nagai, and K. Sanada, “A Case of Drug-Induced Thrombocytopenia Resulting from Sensitivity to Oxaliplatin,” Gan to kagaku ryoho. Cancer & chemotherapy, vol. 42, no. 12, pp. 2157–2159, 2015. View at Google Scholar · View at Scopus
  10. Y. S. Park, J. Ji, J. R. Zalcberg, M. El-Serafi, A. Buzaid, and M. Ghosn, “Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry,” Asia-Pacific Journal of Clinical Oncology, vol. 11, no. 4, pp. 334–342, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. M.-L. Liu, L.-Y. Chien, C.-J. Tai, K.-C. Lin, and C.-J. Tai, “Effectiveness of traditional Chinese medicine for liver protection and chemotherapy completion among cancer patients,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 291843, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Hu, S.-S. Wang, and Q. Du, “Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: from bench to bedside,” World Journal of Hepatology, vol. 7, no. 9, pp. 1209–1232, 2015. View at Publisher · View at Google Scholar
  13. F. Qi, L. Zhao, A. Zhou et al., “The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer,” Bioscience Trends, vol. 9, no. 1, pp. 16–34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. S. Bai, Z. P. Wu, and X. C. Wang, “Advances in research on adjuvant effects applying Traditional Chinese Medicine in cancer chemotherapy,” Journal of Modern Oncology, vol. 18, no. 3, pp. 597–601, 2010. View at Google Scholar
  15. J. Li, H. S. Lin, and W. Hou, “Idea and strategy of traditional Chinese medicine treatment for cancer,” Chinese Journal of Cancer, vol. 28, no. 1, pp. 70–76, 2010. View at Google Scholar
  16. Y. Guo, Y. Huang, H. Shen et al., “Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 840742, 8 pages, 2015. View at Publisher · View at Google Scholar
  17. J. Tian, W.-H. Wang, H.-M. Cao, and Z.-M. Wang, “Determination of matrine, sophoridine and oxymatrine in compound Kushen injection by HPLC,” Zhongguo Zhongyao Zazhi, vol. 32, no. 3, pp. 222–224, 2007. View at Google Scholar · View at Scopus
  18. W. Wang, R. L. You, W. J. Qin et al., “Anti-tumor activities of active ingredients in Compound Kushen Injection,” Acta Pharmacologica Sinica, vol. 36, no. 6, pp. 676–679, 2015. View at Publisher · View at Google Scholar
  19. L. Qi, J. Zhang, and Z. Zhang, “Determination of four alkaloids in compound Kushen Injection by high performance liquid chromatography with ionic liquid as mobile phase additive,” Chinese Journal of Chromatography, vol. 31, no. 3, pp. 249–253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. L. M. Xia, “Clinical research progress of Compound Kushen Injection in treatment of malignant tumor,” Journal of Clinical Oncology and Rehabilitation, vol. 18, no. 4, pp. 365–367, 2011. View at Google Scholar
  21. Q. Sun, W. Ma, Y. Gao, W. Zheng, B. Zhang, and Y. Peng, “Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 9, no. 2, pp. 178–188, 2012. View at Publisher · View at Google Scholar
  22. X. Y. Wu, V. C. H. Chung, P. Lu et al., “Chinese herbal medicine for improving quality of life among nonsmall cell lung cancer patients: overview of systematic reviews and network meta-analysis,” Medicine, vol. 95, no. 1, Article ID e2410, pp. 1–12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Sun, H. Cao, and L. Sun, “Antitumor activities of kushen: literature review,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 373219, 11 pages, 2012. View at Publisher · View at Google Scholar
  24. S.-K. Zhou, R.-L. Zhang, Y.-F. Xu, and T.-N. Bi, “Antioxidant and immunity activities of Fufang Kushen Injection Liquid.,” Molecules (Basel, Switzerland), vol. 17, no. 6, pp. 6481–6490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Zhang, B. Cheng, H. Li et al., “Matrine inhibits proliferation and induces apoptosis of human colon cancer LoVo cells by inactivating Akt pathway,” Molecular Biology Reports, vol. 41, no. 4, pp. 2101–2108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Chang, S.-P. Liu, C.-H. Fang et al., “Effects of matrine on the proliferation of HT29 human colon cancer cells and its antitumor mechanism,” Oncology Letters, vol. 6, no. 3, pp. 699–704, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. X. S. Wang and B. Liu, “Clinical study of compound kushen injection combined with chemotherapy in the treatment of patients with advanced colon cancer,” Research of Integrated Traditional Chinese and Western Medicine, vol. 7, no. 2, pp. 78–80, 2015. View at Google Scholar
  28. W. Hou, J. Liu, W.-G. Shi, and H.-S. Lin, “Multi-center, randomized, controlled clinical study of radiation pneumonitis treated with compound matrine injection in primary lung cancer patients,” Chinese Journal of New Drugs, vol. 22, no. 17, pp. 2065–2068, 2013. View at Google Scholar · View at Scopus
  29. C. L. Tao and J. F. Xu, “Effect of compound kushen injection combined with chemotherapy in the treatment of 74 patients with advanced colon cancer,” Guiding Journal of Traditional Chinese Medicine and Pharmacy, vol. 19, no. 11, pp. 42–44, 2013. View at Google Scholar
  30. X.-Y. Zeng, H. Wang, F. Bai et al., “Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target,” British Journal of Pharmacology, vol. 172, no. 17, pp. 4303–4318, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Li, Q. H. Zhang, S. Wu et al., “Clinical study of compound kushen injection combined with chemotherapy in the treatment of patients with advanced colon cancer,” Liaoning Journal of Traditional Chinese Medicine, vol. 42, no. 5, pp. 1021-1022, 2015. View at Google Scholar
  32. Y. J. Bao, X. Y. Kong, L. P. Yang et al., “Complementary and alternative medicine for cancer pain: an overview of systematic reviews,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 170396, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Kang, L. Min, and D. Wei, “Effect of compound kushen injection combined with conventional chemotherapy in the treatment of colon cancer clinical observation,” Peoples Military Surgeon, vol. 58, no. 11, pp. 1336-1337, 2015. View at Google Scholar
  34. J. F. Gao and G. Feng, “Compound kushen injection combined with chemotherapeutic drugs in the treatment of 40 cases with advanced colon cancer,” China Pharmaceutic, vol. 23, no. 24, pp. 103–105, 2014. View at Google Scholar
  35. R. R. Li and H. S. Li, “Effect of compound kushen injection combined with chemotherapy in the treatment of 35 patients with advanced colon cancer,” Tianjin Pharmacy, vol. 27, no. 4, pp. 50-51, 2015. View at Google Scholar
  36. X. G. Liu, “Feasibility analysis of compound kushen injection combined with chemotherapy in the treatment of patients with advanced colon cancer,” Chinese Journal of Modern Drug Application, vol. 8, no. 19, pp. 150-151, 2014. View at Google Scholar
  37. H. W. Qi, “Study of compound kushen injection combined with chemotherapy in the treatment of patients with advanced colon cancer,” Liaoning Journal of traditional Chinese Medicine, vol. 43, no. 3, pp. 547-548, 2016. View at Google Scholar
  38. L. J. Zheng, E. G. Pang, Z. W. Yang, Z. P. Xiong, J. L. Xing, and J. Ma, “Clinical observation of compound kushen injection in the treatment of colon cancer,” Nei Mongol Journal of Traditional Chinese Medicine, vol. 30, no. 10, pp. 1-2, 2011. View at Google Scholar
  39. L. Xu, “The efficacy of compound kushen injection combined with chemotherapy in the treatment of patients with advanced colon cancer,” Contemporary Medicine Forum, vol. 12, no. 11, pp. 38-39, 2014. View at Google Scholar
  40. Z. J. Wang, Z. Zhou, and L. Bai, “Combination of traditional Chinese and Western medicine in the treatment of 66 cases of colon cancer,” Journal of the Chinese Medical Association, vol. 31, no. 36, pp. 86–88, 2015. View at Google Scholar
  41. H. Ren, J. Sun, and L. X. Zhang, “Effect of compound kushen injection combined with chemotherapy in the treatment of colon cancer,” China Health CareNutrition, no. 5, pp. 2468-2469, 2014. View at Google Scholar
  42. X. G. Fang and K. S. Zhang, “Analysis on the clinic effect of compound Sophora Flavescens injection plus chemotherapy on Terminal Colorectal Cancer,” Anti-Tumor Pharmacy, vol. 2, no. 4, pp. 293-294, 2012. View at Google Scholar
  43. M. Xiang and A. H. Liu, “Effect of compound kushen injection combined with raltitrexed and oxaliplatin for the treatment of advanced colorectal cancer,” Drugs & Clinic, vol. 31, no. 1, pp. 84-85, 2016. View at Google Scholar
  44. J. P. T. Higgins and S. G. Thompson, “Quantifying heterogeneity in a meta-analysis,” Statistics in Medicine, vol. 21, no. 11, pp. 1539–1558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Mantel and W. Haenszel, “Statistical aspects of the analysis of data from retrospective studies of disease,” Journal of the National Cancer Institute, vol. 22, no. 4, pp. 719–748, 1959. View at Publisher · View at Google Scholar
  46. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Tian and J.-S. Chen, “Time trends of incidence of digestive system cancers in changle of China during 1988-2002,” World Journal of Gastroenterology, vol. 12, no. 28, pp. 4569–4571, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Zippi, G. De Toma, G. Minervini et al., “Desmoplasia influenced recurrence of disease and mortality in stage III colorectal cancer within five years after surgery and adjuvant therapy,” Saudi Journal of Gastroenterology, vol. 23, no. 1, pp. 39–44, 2017. View at Publisher · View at Google Scholar · View at Scopus
  49. L.-C. Moreau, R. Rajan, M. P. Thirlwell, and T. Alcindor, “Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting,” Anticancer Reseach, vol. 33, no. 4, pp. 1765–1768, 2013. View at Google Scholar · View at Scopus
  50. C. Luo, Y. Zhu, T. Jiang et al., “Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family,” Toxicology, vol. 229, no. 3, pp. 245–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. W. Ho JW NganHonPL. Chim O, “Efects ofoxymatrine from Ku Shen on cancer cells,” Antieancer Agen-Med Chem, vol. 9, no. 8, pp. 823–826, 2009. View at Publisher · View at Google Scholar
  52. T. T. Zhang, R. M. Wang, Z. Yang, and G. B. Chen, “Dual inhibiting EGFR and VEGF pathways versus EGFR-TKIs alone in the treatment of advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials,” Clinical and Translational Oncology, vol. 18, no. 6, pp. 576–581, 2016. View at Publisher · View at Google Scholar · View at Scopus